Genotyping Market to Reach USD 44.9 Billion by 2030, Expanding at a Robust CAGR of 14.6%

11
Airborne ISR Market
Airborne ISR Market

The genotyping market, valued at USD 15.1 billion in 2022, is set for substantial growth, with projections indicating it will reach USD 44.9 billion by 2030. This significant expansion represents a compound annual growth rate (CAGR) of 14.6% over the forecast period from 2023 to 2030.

Market Overview

The genotyping market is experiencing accelerated growth due to advancements in genetic research, increasing applications in personalized medicine, and rising demand for genetic testing. Genotyping, which involves analyzing genetic variations, plays a crucial role in understanding genetic predispositions to diseases, guiding treatment strategies, and advancing research.

Get Free Sample Report: https://www.snsinsider.com/sample-request/3813 

KEY MARKET SEGMENTATION

By Product

  • Instruments
  • Reagents & Kits
  • Software and Services

In 2022, Reagents & Kits segment is expected to held the highest market share of 61.8% during the forecast period due to rising demand for generic testing, increasing investment in R & D expenditure and rising genotyping testing volume.

By Technology

  • PCR
  • Capillary Electrophoresis
  • Microarrays
  • Sequencing
  • Mass Spectrometry
  • Others

In 2022, Sequencing segment is expected to held the highest market share of 21.2% during the forecast period. It is expected to grow at a lucrative rate during the forecast period due to greater specificity and the ability to detect low expression and differentially expressed genes more effectively than other approaches. Genotyping by sequencing also makes it possible to do comparative analysis across samples without the use of a reference genome.

By Application

  • Pharmacogenomics
  • Diagnostics and Personalized Medicine
  • Agricultural Biotechnology
  • Animal Genetics
  • Others

Key Drivers of Market Growth

  • Advancements in Genetic Research: Ongoing developments in genomics and biotechnology are enhancing genotyping technologies. Innovations in high-throughput sequencing and genotyping platforms are driving market growth by improving accuracy and efficiency.
  • Rising Demand for Personalized Medicine: The increasing focus on personalized and precision medicine is boosting the need for genotyping. Tailoring treatments based on genetic profiles offers more effective and targeted healthcare solutions, fueling market expansion.
  • Growing Adoption of Genetic Testing: The rising awareness and accessibility of genetic testing services are contributing to market growth. Consumers and healthcare providers are increasingly utilizing genetic tests for disease risk assessment, ancestry analysis, and wellness.
  • Expansion of Research and Development: Increased investments in research and development by pharmaceutical companies, research institutions, and healthcare organizations are driving innovations in genotyping technologies and applications.

Regional Insights

  • North America: Leads the genotyping market due to advanced healthcare infrastructure, significant investments in genetic research, and high adoption rates of new technologies. The region benefits from a strong presence of key market players and well-established genetic testing services.
  • Europe: Shows steady growth driven by increasing applications of genotyping in medical research, personalized medicine, and rising healthcare investments. The region’s focus on genetic research and healthcare innovation supports market expansion.
  • Asia-Pacific: Expected to experience rapid growth due to rising healthcare investments, expanding research initiatives, and increasing awareness of genetic testing. The region’s large patient population and improving access to genetic technologies contribute to its growth.

Market Forecast

The genotyping market is projected to achieve significant growth, with an estimated value of USD 44.9 billion by 2030. The market is anticipated to grow at a robust CAGR of 14.6% from 2023 to 2030, driven by technological advancements, rising demand for personalized medicine, and increased adoption of genetic testing services.

Other Related Reports

Demineralized Bone Matrix (DBM) Market Share

Blood Pressure Monitors Market Share

Assisted Reproductive Technology Market Share

Allergic Conjunctivitis Market Share

Pressure ulcer treatment market Share

About SNS Insider

SNS Insider is a leading global provider of data and analytics, renowned for delivering accurate consumer and market insights. Our success is built on the trust of our clients and industry innovation. Our expert team of engineers, consultants, and data scientists employs advanced methodologies and technologies to provide actionable insights and support strategic decision-making.

Contact Us:

Akash Anand
Head of Business Development & Strategy
Email: info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: https://www.snsinsider.com/